National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

BAY 43-9006

 A drug used to treat advanced kidney cancer and a type of liver cancer that cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. BAY 43-9006 stops cells from dividing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of kinase inhibitor and a type of antiangiogenesis agent. Also called Nexavar, sorafenib, and sorafenib tosylate.



Previous Definitions:baseline, basophil, batimastat, batracylin, BAY 12-9566
Next Definitions:BAY 56-3722, BAY 59-8862, BB-10901, BBBD, BBIC

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov